About Us
Our Goals
Systematic Process
Research
Resources
Contact Us
Our Goals

NFAM is committed to prospective clinical research to obtain the most valuable data.

 

Martha Villar, MD (Director of EsSaludÕs CAM Program) at one of 19 EsSalud CAM clinics. With a 2007 government mandate, the CAM clinics will be expanded to all EsSalud hospitals across Peru.

 

Investigation
Search the world for effective, nontoxic, and low-cost alternative medical therapies

Research
Develop clinical research programs to demonstrate the effectiveness of these treatments

Implementation
Disseminate information to encourage adoption of innovative, alternative therapies

Progress in the field of complementary and alternative medicine is frustratingly slow.  In some cases practitioners are untrained in clinical research methods, or may lack preliminary data beyond patient testimonials.  Limited financial resources, inadequate research capacity, or inappropriate models to screen novel therapies also slow research. NFAM provides a service to the field by assisting researchers and practitioners in collecting clinical outcomes data.

NFAM is committed to prospective clinical research to obtain the most valuable data. Throughout the world, NFAM is developing collaborations with hospitals and clinical sites where it can conduct research on treatments that meet the economic needs of the host country.  These countries often have very limited access to pharmaceutical drugs. Unlike the United States, countries within Africa and South America often have much stronger traditions and legal structures for integrating complementary and alternative therapies into public health systems.  Several governments have now committed to collaborating with NFAM on clinical research.  This research could lead the way towards larger, more definitive trials leading to the release of real breakthroughs in world health.

NFAM is eager to collaborate with groups outside the U.S. who have the research capacity and interest in advancing investigations of non-toxic, innovative, and cost-effective therapies for conditions with a large public health impact.